CyberKnife Market Size, Share and Growth Outlook, 2026

CyberKnife Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global CyberKnife Market size is forecast to increase from $869.22 Million in 2026 to $3010.73 Million in 2034 at a CAGR of 16.8% between 2026 and 2034.

The CyberKnife market report provides detailed analysis and outlook of CyberKnife segments including By System Configuration (Fixed CyberKnife Systems, Robotic-Arm CyberKnife Systems, Upgraded and Refurbished Systems), By Technology (Robotic Radiosurgery Systems, Adaptive Radiotherapy Systems, Image-Guided Radiation Therapy, Linear Accelerator-Based Systems), By Application (Oncology, Benign Tumor Treatment, Vascular Malformations, Functional and Neurological Disorders), By Anatomical Site (Brain and Central Nervous System, Spine, Lung, Prostate, Liver and Pancreas), By End User (Hospitals and Specialized Cancer Centers, Radiotherapy Clinics, Ambulatory Surgical Centers, Academic and Research Institutes) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

CyberKnife Industry Overview

Clinical Evidence Reinforcing the Effectiveness of CyberKnife Radiosurgery

The CyberKnife industry continues to advance as healthcare providers increasingly adopt robotic stereotactic radiosurgery systems for the treatment of localized and metastatic cancers. CyberKnife technology is widely recognized for its ability to deliver highly precise radiation doses while minimizing exposure to surrounding healthy tissues. Recent clinical evidence has strengthened confidence in the effectiveness of various CyberKnife treatment protocols. A large international oncology study evaluated two stereotactic body radiation therapy regimens delivered through CyberKnife technology, comparing 35 Gy administered in five fractions with 36 Gy delivered in four fractions across 249 patients. Long-term follow-up demonstrated nearly identical three-year biochemical recurrence-free survival rates of 96.5% and 96.8%, respectively, while maintaining minimal treatment-related toxicities. These findings highlight the consistency and reliability of CyberKnife-based treatment approaches in achieving favorable clinical outcomes.

Integration of Artificial Intelligence and Advanced Treatment Planning

Technological innovation remains a major driver within the CyberKnife market as manufacturers and healthcare providers seek to further improve treatment precision and patient safety. Industry reviews have highlighted the growing integration of artificial intelligence into robotic radiosurgery workflows. Current clinical strategies increasingly combine high-accuracy stereotactic tracking capabilities with AI-driven target volume simulations designed to improve treatment planning and reduce radiation exposure to adjacent healthy tissues. These advanced simulation tools help clinicians optimize dose delivery while minimizing the risk of radiation necrosis and other treatment-related complications. The incorporation of real-time imaging, automated planning technologies, and intelligent tracking systems is strengthening the role of CyberKnife platforms in precision oncology and advanced radiation therapy applications.

Growing Synergy Between Radiosurgery and Immunotherapy

A significant trend shaping the CyberKnife industry is the increasing use of stereotactic radiosurgery in combination with modern systemic cancer therapies. Clinical research has demonstrated the potential benefits of pairing ultra-hypofractionated stereotactic radiotherapy with programmed death receptor-1 (PD-1) inhibitors and other immune checkpoint therapies. Data from a large multicenter cohort study showed that combining highly targeted radiation delivery with immunotherapy can stimulate systemic antitumor responses, commonly referred to as abscopal effects. The combination approach significantly improved progression-free survival among patients with refractory metastatic disease. These findings are encouraging broader adoption of integrated treatment strategies that combine the precision of CyberKnife technology with the systemic benefits of immunotherapy, expanding the role of robotic radiosurgery within multidisciplinary cancer care programs.

CyberKnife Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global CyberKnife market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Accuray Incorporated, Elekta AB, Siemens Healthineers AG (Varian Medical Systems), GE HealthCare Technologies Inc., IBA Worldwide, Hitachi High-Tech Corporation, Sumitomo Heavy Industries, Ltd., ViewRay Technologies, Inc., Perspective Therapeutics, Inc., Brainlab AG. The CyberKnife market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the CyberKnife industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth CyberKnife Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by CyberKnife companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional CyberKnife markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

CyberKnife Market Competitive Benchmarking and Company Analysis

Leading companies in CyberKnife industry include- Accuray Incorporated, Elekta AB, Siemens Healthineers AG (Varian Medical Systems), GE HealthCare Technologies Inc., IBA Worldwide, Hitachi High-Tech Corporation, Sumitomo Heavy Industries, Ltd., ViewRay Technologies, Inc., Perspective Therapeutics, Inc., Brainlab AG. The CyberKnife market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US CyberKnife Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the CyberKnife market remains one of the strongest-performing segments in the country.
The US CyberKnife Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US CyberKnife market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across CyberKnife industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian CyberKnife markets

Canada's strong CyberKnife sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian CyberKnife market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany CyberKnife Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest CyberKnife market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of CyberKnife population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany CyberKnife industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the CyberKnife market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support CyberKnife sales through 2034

France CyberKnife companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK CyberKnife Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of CyberKnife distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China CyberKnife Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China CyberKnife market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of CyberKnife industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese CyberKnife industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India CyberKnife Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian CyberKnife market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil CyberKnife market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa CyberKnife Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

CyberKnife Market Segmentation

By System Configuration
Fixed CyberKnife Systems
Robotic-Arm CyberKnife Systems
Upgraded and Refurbished Systems
By Technology
Robotic Radiosurgery Systems
Adaptive Radiotherapy Systems
Image-Guided Radiation Therapy
Linear Accelerator-Based Systems
By Application
Oncology
Benign Tumor Treatment
Vascular Malformations
Functional and Neurological Disorders
By Anatomical Site
Brain and Central Nervous System
Spine
Lung
Prostate
Liver and Pancreas
By End User
Hospitals and Specialized Cancer Centers
Radiotherapy Clinics
Ambulatory Surgical Centers
Academic and Research Institutes

Top Companies in CyberKnife Industry

Accuray Incorporated
Elekta AB
Siemens Healthineers AG (Varian Medical Systems)
GE HealthCare Technologies Inc.
IBA Worldwide
Hitachi High-Tech Corporation
Sumitomo Heavy Industries, Ltd.
ViewRay Technologies, Inc.
Perspective Therapeutics, Inc.
Brainlab AG

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025